Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An immunologic disorder characterized by recurrent mainly sinopulmonary infections associated with increased serum IgE. The phenotype is variable, even within families. Some patients have onset of symptoms in early childhood and develop complications, including bronchiectasis or hemoptysis, whereas others have later onset of less severe infections. Immunologic workup usually shows normal leukocyte levels, although some patients may demonstrate alterations in lymphocyte subsets, including T cells. Affected individuals also have variable skeletal abnormalities, including high-arched palate, hyperextensible joints, scoliosis, and bone fractures. The IL6ST mutations are loss-of-function, although the truncated mutant proteins are expressed and interfere with the wildtype protein in a dominant-negative manner by disrupting IL6 and IL11 signaling.
Features include always present findings: Increased circulating IgE concentration; and very common findings: Recurrent pneumonia and Persistence of primary teeth. 26 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 6 | Bronchomalacia, Recurrent pneumonia, Pulmonary pneumatocele |
IL6ST encodes interleukin 6 cytokine family signal transducer (918 aa). Signal-transducing molecule. The receptor systems for IL6, LIF, OSM, CNTF, IL11, CTF1 and BSF3 can utilize IL6ST for initiating signal transmission. Highest expression in Cells Cultured fibroblasts (214.0 TPM) and Adipose Visceral Omentum (117.2 TPM).
Hyper-IgE recurrent infection syndrome 4A, autosomal dominant is associated with mutations in the IL6ST gene on chromosome 5.
The IL6ST protein participates in JAK1,JAK2,(TYK2) bind IL6ST and CDH1,CDH11 promote stabilization of IL6ST protein pathways.
IL6ST is classified as a druggable target (Clinically Actionable, Druggable Genome, External Side Of Plasma Membrane, Kinase, and Tyrosine Kinase categories) with score 7.0.
Genetic testing for IL6ST is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 2 very common features, 11 common features.
No clinical trials have been registered for hyper-IgE recurrent infection syndrome 4A, autosomal dominant.
2 publications have been identified in PubMed for hyper-IgE recurrent infection syndrome 4A, autosomal dominant. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Ashihara K (2025). [PMID: 40526438](https://pubmed.ncbi.nlm.nih.gov/40526438/). *JCI insight*. [Basic Science / Preclinical]
Narahari NK (2024). [PMID: 39465929](https://pubmed.ncbi.nlm.nih.gov/39465929/). *Lung India : official organ of Indian Chest Society*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
Online Mendelian Inheritance in Man
Bones and joints
3 |
Increased susceptibility to fractures, Sideways curvature of the spine (scoliosis), Joint hypermobility |
Blood and immune system | 3 | Recurrent skin infections, Recurrent upper respiratory tract infections, Decreased total neutrophil count |
Skin | 2 | Atopic dermatitis, Recurrent skin infections |
Lab test results | 1 | Increased circulating IgE concentration |
Head and neck | 1 | High palate |